NCT06631534View on ClinicalTrials.gov

Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atrial Septal Defect (ASD)DexmedetomidineDelirium - PostoperativeStress Response
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine 1ug/kg bolus administered over 10 minutes followed by a continuous infusion of 0.5ug/kg/hr

DRUG

Saline (NaCl 0,9 %) (placebo)

Saline (placebo)

Trial Locations (1)

Unknown

RECRUITING

Alexandria University Hospitals - Semouha, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER